DAIC

MARCH 15, 2024

It serves as a publication vehicle for early career cardiologists and members of the cardiovascular care team, providing a forum for mentorship on the review and publication process. Widely recognized for pioneering innovative concepts and techniques in TAVR, Tang has set contemporary standards in the field.

TAVR 52

TAVR Academic Education Cardiovascular Surgery 52

DAIC

APRIL 5, 2024

The acquisition of Shockwave further extends Johnson & Johnson MedTech’s position in cardiovascular intervention and accelerates its shift into higher-growth markets. Cardiovascular intervention is one of the fastest-growing global medtech markets, with significant unmet patient need.

Cardiovascular Interventions 105

Cardiovascular Interventions Technology Innovation Angina 105

DAIC

MAY 31, 2024

Joaquin Duato , Chairman and Chief Executive Officer of Johnson & Johnson, said, “Through Innovative Medicine and MedTech, Johnson & Johnson is transforming the trajectory of cardiovascular disease, one of the leading causes of death globally.

Peripheral Arterial Disease 104

Peripheral Arterial Disease Innovation Coronary Artery Disease Cardiovascular Interventions 104

DAIC

FEBRUARY 14, 2025

Amputation statistics are bleak, and amputation should be a last resort, said Dr. Shishehbor, President of UH Harrington Heart & Vascular Institute, and Angela and James Hambrick Chair in Innovation at UH. This is why we are passionate about pursuing alternatives to amputation for our patients. When we save a limb, we save a life.

Peripheral Arterial Disease 52

Peripheral Arterial Disease Cancer Innovation Best Practices 52

Cardiometabolic Health Congress

JULY 17, 2024

February 2024 FDA Approvals: Innovations in Cardiovascular Interventions XACT Carotid Stent System (Approved: 02/07/2024) This approval expands the indications to be used during a Transcarotid Artery Revascularization (TCAR) procedure to prevent future strokes.

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Pediatrics 59

DAIC

FEBRUARY 14, 2025

Amputation statistics are bleak, and amputation should be a last resort, said Dr. Shishehbor, President of UH Harrington Heart & Vascular Institute, and Angela and James Hambrick Chair in Innovation at UH. This is why we are passionate about pursuing alternatives to amputation for our patients. When we save a limb, we save a life.

Hospital 52

Hospital Peripheral Arterial Disease Cancer Innovation 52

The Beat Blog

MAY 2, 2023

The pandemic taught us that telehealth, virtual care, and innovative diagnostic technology enable providers and caregivers to expand capabilities, regardless of location. Specialty Solutions The question then is: how do we prepare for and address the problems that rural communities are facing across the country? So what is the way forward?

Atrial Fibrillation 52

Atrial Fibrillation Cardiovascular Disease Technology Hospital 52

Cardiometabolic Health Congress

NOVEMBER 22, 2024

From breakthrough medications to innovative technologies, there is a lot for cardiometabolic clinicians professionals to celebrate. Additionally, the ongoing ORBITA-2 trial examines the use of percutaneous coronary intervention (PCI) for stable angina, offering valuable insights into procedural benefits and outcomes​.

Blood Pressure 59

Blood Pressure Obesity Preserved Ejection Fraction Coronary Artery Disease 59

DAIC

MARCH 17, 2025

is built on more than two decades of experience, leadership and innovation in invasive cardiology to enhance cath labs and EP procedures and empower clinicians to deliver the best possible outcomes, said Jyoti Gera, CEO, CardioVascular & Interventional Solutions, GE HealthCare. AltiX AI.i

Document 59

Document Coronary Artery Disease Innovation Cardiovascular Disease 59